Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Avid Radiopharmaceuticals"
Count: 67
Selected: 0
| NCT ID | Title |
|---|
| NCT05775601 | 18F-LY3950321-01 Biodistribution and Safety Study | ||
| NCT01565382 | Evaluation of Inter-reader Reliability Using Images From Subjects With Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI) | ||
| NCT04721756 | Early Clinical Evaluation of 18F-LY3546117 in Tumor Imaging | ||
| NCT04474405 | Exploratory Evaluation of Flortaucipir Injection in Healthy Volunteers and Cognitively Impaired Subjects | ||
| NCT04468347 | Flortaucipir PET Imaging in the Preclinical, Prodromal and Dementia Phases of Alzheimer's Disease | ||
| NCT03052972 | Flortaucipir 18F PET Imaging in BIOCARD Study | ||
| NCT03040713 | Flortaucipir PET Imaging in Subjects With FTD | ||
| NCT02016560 | Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD Subjects | ||
| NCT02278367 | Clinical Evaluation of Flortaucipir F 18 | ||
| NCT02278354 | Tau Imaging in Professional Fighters | ||
| NCT03901092 | A Reader Study to Assess Accuracy and Reliability of Flortaucipir F 18 Positron Emission Tomography (PET) Scan Interpretation | ||
| NCT02516046 | 18F-AV-1451 Autopsy Study | ||
| NCT02079766 | 18F-AV-1451 and Florbetapir F 18 PET (Positron Emission Tomography) Imaging in Subjects at Risk for Chronic Traumatic Encephalopathy | ||
| NCT02051764 | Imaging Characteristics of a Follow-up 18F-AV-1451 Scan | ||
| NCT01992380 | A Study of Flortaucipir PET in Healthy Volunteers and Cognitively Impaired Subjects | ||
| NCT03901105 | Evaluation of Flortaucipir PET Signal and Cognitive Change in Early Alzheimer's Disease | ||
| NCT02167594 | Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers | ||
| NCT03467477 | Tau Screening Study in Subjects With Early Symptomatic AD | ||
| NCT03322462 | Tau Screening Study in Patients With Early Symptomatic AD | ||
| NCT02795780 | Follow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05 | ||
| NCT02336360 | Augmenting Flortaucipir Dosimetry Estimates | ||
| NCT01515384 | A Trial of 18F-AV-133 Positron Emission Tomography (PET) | ||
| NCT02918539 | Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials | ||
| NCT02350634 | 18F-AV-1451 High Resolution Autopsy Study | ||
| NCT01518374 | Clinical Evaluation of Florbetapir F 18 (18F-AV-45) | ||
| NCT02120664 | Florbetapir Calibration to the Centiloid Scale | ||
| NCT01550484 | A Trial of 18F-AV-133 Positron Emission Tomography (PET) Imaging to Differentiate Subjects With Parkinson's Disease (PD) From Other Movement Disorders | ||
| NCT01703702 | Effectiveness of Florbetapir (18F) PET Imaging in Changing Patient Management and the Relationship Between Scan Status and Cognitive Decline | ||
| NCT02512029 | 18F-AV-1451 PET Imaging in TBI | ||
| NCT01710371 | Quantitative 18F-AV-133 PET Imaging in Subjects With Diabetes and Healthy Controls | ||
| NCT02051790 | Evaluation of Reader Training Processes | ||
| NCT02107599 | The Feasibility of Florbetapir Quantitation in Europe | ||
| NCT01946243 | The Feasibility of Florbetapir Quantitation | ||
| NCT02029547 | Evaluation of Electronic Florbetapir (18F) Interpretation Training in Japanese Physicians | ||
| NCT01890343 | Imaging Characteristics of Florbetapir 18F in Patients With Frontotemporal Dementia, Alzheimer's Disease and Normal Controls. | ||
| NCT01662882 | A Phase II Trial of Florbetapir (18F) Positron Emission Tomography (PET) Imaging in Japan of Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD) | ||
| NCT01660815 | A Study of Florbetapir (18F) in Japanese Healthy Volunteers | ||
| NCT01733355 | A Phase 0, Open Label, Multi-center Exploratory and Safety Study of [F-18]T807 | ||
| NCT01723488 | A Phase 0, Open Label, Multi-Center, Exploratory and Safety Study of [F-18]T808 | ||
| NCT01400425 | Potential of Florbetapir F 18 PET to Inform Clinical Diagnosis and Management of Patients With Progressive Cognitive Decline | ||
| NCT00857506 | Observational Study of Cognitive Outcomes for Subjects Who Have Had Prior PET Amyloid Imaging With Florbetapir F 18 (18F-AV-45) | ||
| NCT00857532 | Florbetapir F 18 PET Imaging of Beta-amyloid in Parkinson's Disease Patients | ||
| NCT01503944 | A Trial of 18F-AV-133 and 18F-AV-45 Positron Emission Tomography (PET) | ||
| NCT00855868 | Ability Of ([18F]-AV-45) PET Scan to Distinguish Alzheimer's Disease Subjects From Cognitively Normal Individuals | ||
| NCT01565330 | A Study of Two Doses of 18F-AV-45 in Alzheimer's Disease and Healthy Volunteers | ||
| NCT01565369 | Evaluation of Physician Training Methods to Read Florbetapir-PET Scans | ||
| NCT01565356 | Evaluation of PET Scan Timing Relative to AV-45 Injection Time | ||
| NCT01550549 | Evaluation of Web-based Training to Educate Physicians in the Methods of Interpreting Florbetapir-PET Scans | ||
| NCT01447719 | Autopsy Follow-up of Subjects Previously Imaged With Florbetapir F 18 (18F-AV-45) PET in Trial 18F-AV-45-A07 | ||
| NCT00857415 | Phase III Study of the Correlation Between Florbetapir F18 PET Imaging and Amyloid Pathology in the Brain |
